RJ

Rajkumar Jain

Director Director DIN 00024137
DIN 00024137 First appointment Aug 1989 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 1989
Shareholding value •••• Premium profile

About Rajkumar Jain

Data last updated:

Rajkumar Jain was a Director at Rexel Pharma (India) Private Limited (2000–2008) and Director at Raj Pioneer Laboratories India Private Limited (1989–2008). The companies operate in Chemicals and Chemicals and Materials.

DIN 00024137
Primary Designation Director
Industry Chemicals
First Appointment 22 Aug 1989

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rexel Pharma (India) Private Limited U24230MH2000PTC129343
Director24 Oct 20002000Strike Off
Director22 Aug 19891989₹125 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rexel Pharma (India) Private Limited
Raj Pioneer Laboratories India Private Limited
Premium access

Shareholding and investment profile for Rajkumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajkumar Jain

Rajkumar Jain was first appointed on 22 Aug 1989 as Director at Raj Pioneer Laboratories India Private Limited. The most recent appointment on record is 24 Oct 2000 at Rexel Pharma (India) Private Limited.

Rajkumar Jain held 2 earlier board appointments: Rexel Pharma (India) Private Limited (Director, 24 Oct 2000 to 31 Mar 2008); Raj Pioneer Laboratories India Private Limited (Director, 22 Aug 1989 to 28 Mar 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available